TITakashi Ichikura

Takashi Ichikura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takashi Ichikura has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Chemotherapy with Cisplatinum and 5-FU in a Patient with Esophageal Cancer

    by Daisaku Morita, Takashi Ichikura, Mikihiko Kimura, Kentaro Chochi, Susumu Saigusa, Yoshihisa Yaguchi, Naoko Sakamoto, Hidetaka Mochizuki


    • 1 July 2003
      • Vol. 104  (7) , 499-505

    [The pathogenesis of the systemic inflammatory response syndrome and compensatory antiinflammatory response syndrome following surgical stress].

    by Satoshi Ono, Takashi Ichikura, Hidetaka Mochizuki

    The inflammation charge cells such as the macrophages, neutrophils, endothelial cells, and fibroblasts are activated in surgical sites when tissue injury occurs due to the operation. Proinflammatory cytokines such as tumor necrosis factor alpha, interleukin (IL)-1, IL-6, and IL-8 are induced from the activated inflammation charge cells. These cytokines amplify the information by autocrine and paracrine action, induce the production of other cytokines, and send the information to the whole body. Increases in body temperature, pulse rate, and leukocyte counts are then observed. This condition is called the systemic inflammatory response syndrome (SIRS) clinically. On the other hand, the production of antiinflammatory cytokines against SIRS is induced simultaneously. The condition in which antiinflammatory cytokines are produced in excess and become dominant systemically is called the compensatory antiinflammatory response syndrome (CARS). No standard concrete diagnosis for CARS has been established, although CARS is a pathogenetic concept. However, recently the analysis of cytokine production and various types of surface molecules in the inflammation charge cells became possible with the development of molecular biological methods. As a result, it was found that the immune system is controlled by the balance between proinflammatory and antiinflammatory cytokine production, and if the compensatory antiinflammatory reaction is sufficiently severe, it will manifest clinically as anergy, with increased susceptibility to infection. In this manuscript, we explain the pathogenesis of SIRS and CARS following surgical stress by analyzing cytokine production and surface membrane molecules in the inflammation charge cells.


  • Is Adenocarcinoma of the Gastric Cardia a Distinct Entity Independent of Subcardial Carcinoma?

    by Takashi Ichikura, Toshiya Ogawa, Toshinobu Kawabata, Kentaro Chochi, Hidekazu Sugasawa, Hidetaka Mochizuki

    Cardia carcinoma has been defined diversely. The purpose of this study was to determine whether cardia carcinoma should be categorized as a distinct entity independent of subcardial carcinoma. We retrospectively analyzed 65 patients undergoing resection for adenocarcinoma involving the esophagogastric junction (EGJ) with the tumor center within 5 cm of the EGJ. Adenocarcinomas of the EGJ were classified into Type I, Type II, and Type III according to Siewert’s criteria. There was only one Type I adenocarcinoma, and it was associated with Barrett’s esophagus. No tumors had their center between 1 cm and 2 cm proximal to the EGJ. Clinicopathologic features and prognosis were compared among patients with Type II adenocarcinomas (n = 31), patients with Type III adenocarcinomas (n = 33), and patients with adenocarcinomas in the upper third of the stomach not invading the EGJ (n = 153). Siewert’s Type II adenocarcinoma was associated with a higher male/female ratio and with higher incidences of well-demarcated appearance and differentiated histology than carcinoma of the upper third of the stomach without esophageal invasion. Lymph nodes along the greater curvature and parapyloric nodes were rarely involved in Type II tumors. Within the pT2 category, patients with Siewert’s Type II tumors showed a higher incidence of lymph node metastasis and a significantly lower survival rate than did patients with tumors of the upper third of the stomach without esophageal invasion. In conclusion, cardia carcinoma, appropriately defined as adenocarcinoma with its epicenter between 1 cm proximal and 2 cm distal to the EGJ, should be categorized as a distinct entity.


  • Minimum Number of Lymph Nodes that Should Be Examined for the International Union Against Cancer/American Joint Committee on Cancer TNM Classification of Gastric Carcinoma

    by Takashi Ichikura, Toshiya Ogawa, Kentaro Chochi, Toshinobu Kawabata, Hidekazu Sugasawa, Hidetaka Mochizuki

    The classification of lymph node metastasis based on the number of positive nodes has been adopted in the International Union Against Cancer/American Joint Committee on Cancer (UICC/AJCC) TNM classification of gastric carcinoma. However, the N classification (for condition of the regional lymph nodes) would be underestimated when the number of examined nodes were too small. To determine the minimum number of lymph nodes to examine for a correct classification, we analyzed 926 patients undergoing curative resection for gastric carcinoma. The number of metastatic lymph nodes correlated significantly with the number of examined lymph nodes. The pN0 patients with 10 to 14 examined nodes showed a significantly higher survival rate than did those with 5 to 9 examined nodes, and they had as good a prognosis as those with 15 or more examined nodes. In the pN1 and pN2 categories, patients with 29 or fewer examined nodes tended toward lower survival rates than did patients with 30 or more examined nodes. Among the patients who were classified as stage IA, the survival rate for those with 5 to 9 examined nodes was significantly lower than that for patients with 30 or more examined nodes. Among the patients classified as stage III, those with 10 to 19 examined nodes and those with 20 to 29 examined nodes had lower survival rates than did patients with 30 or more examined nodes. In conclusion, the minimum number of lymph nodes examined for a correct pN0 classification can be reduced from 15 to 10. For pN1–3 classifications, 20 or more nodes should be examined, and examining 30 or more lymph nodes may be desirable.


    • 10 August 2002
      • Vol. 22, 1193-9

    The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma.

    by Takashi Majima, Takashi Ichikura, Shuhji Seki, Eiji Takayama, Atsushi Matsumoto, Toshinobu Kawabata, Kentaro Chochi, Hoshio Hiraide, Hidetaka Mochizuki

    Although the peritoneal cavity (PC) is the most common site of metastasis in gastric carcinoma, its immune status in patients with advanced cancer remains largely unknown. We investigated the relationship between clinical parameters and cytokine levels in the PC and also evaluated IFN-y production by peritoneal exudate cells (PEC), obtained during surgery from patients with stage III-IV gastric carcinoma. Although the IFN-gamma and IL-12 levels in the PC did not differ between stage III and stage IV cancer patients, the latter had higher levels of IL-10 and IL-18. Those patients with higher IFN-gamma levels experienced a significantly better survival-rate than those with lower IFN-gamma levels, whereas IL-18 (but not IL-10) levels were inversely-correlated with survivaL IFN-gamma levels increased in parallel with IL-18 levels in patients who survived more than two years, but this correlation did not apply to patients who died of disease within two years. In addition, anti-CD3-Ab or cytokine- stimulated PEC from patients with low IL-10 levels in their PC produced a significantly greater amount of IFN-gamma than PEC from patients with high PC IL-10 levels. In conclusion, a high level of IFN-y in the PC is an indicator of favorable outcome. Both IL-10 and IL-18 levels in the PC increased with tumor progression. Although the number of PEC capable of producing IFN-gamma increases with tumor progression, their ability to secrete IFN-gamma in response to IL-18 may be influenced by local IL-10 levels in the PC.


  • Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF‐C in gastric carcinoma

    by Takashi Ichikura, Soichi Tomimatsu, Eiji Ohkura, Hidetaka Mochizuki

    Background and Objectives: Angiogenic factors play a major role in tumor growth and metastasis. The purpose of this study was to clarify the prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF‐C in gastric carcinoma. Methods: Formalin‐fixed and paraffin embedded sections of tumor tissue were obtained from 76 patients who underwent curative gastrectomy for gastric carcinoma. Immunohistochemical staining for VEGF and VEGF‐C was performed. Results: VEGF and VEGF‐C were positively expressed in 39 and 45% of the patients, respectively. No correlation existed between VEGF and VEGF‐C expressions. VEGF expression was significantly correlated with venous invasion. VEGF‐C expression was significantly correlated with lymphatic and venous invasion. Patients with positive staining for VEGF showed a significantly lower survival rate than VEGF negative patients. After subdivision, according to the combination of VEGF and VEGF‐C expression, VEGF‐C expression had a significant unfavorable impact on prognosis among patients with negative staining for VEGF. The expression of VEGF and/or VEGF‐C was independent prognostic determinant by the multivariate survival analysis. Conclusion: The positive expression for VEGF and/or VEGF‐C was an important prognostic determinant after curative gastrectomy for gastric carcinoma. VEGF‐C may stimulate the tumor progression in the absence of VEGF. J. Surg. Oncol. 2001;78:132–137.


  • The detection of microbial DNA in the blood in surgical patients

    by Akira Yamauchi, Satoshi Ono, Suefumi Aosasa, Hironori Tsujimoto, Atsushi Matsumoto, Takashi Ichikura, Hidetaka Mochizuki

  • Interleukin-12 and -18 induce a severe liver injury in mice recovered from peritonitis by subsequent sublethal endotoxin challenge

    by Satoshi Ono, Shuji Seki, Chikara Ueno, Suefumi Aosasa, Atsushi Matsumoto, Akira Yamauchi, Takashi Ichikura, Hoshio Hiraide, Hidetaka Mochizuki